Microba has reported a significant revenue growth of 99% for the third quarter of the fiscal year 2026. Despite this impressive increase in revenue, the company is facing cash constraints that may impact its operations. The financial results highlight the challenges the company is navigating while experiencing substantial sales growth. Further details regarding the company's strategies to address these cash flow issues were not disclosed.
Related Articles
Don't miss out on breaking stories and in-depth articles.